Igene Biotechnology, Inc.
IGNE
$0.00
$0.000.00%
OTC PK
| 09/30/2010 | 06/30/2010 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -52.13% | 41.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 15.89% | -28.46% | |||
| Total Operating Expenses | -24.64% | -14.23% | |||
| Operating Income | 24.64% | 14.23% | |||
| Income Before Tax | 22.68% | -47.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 22.68% | -47.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 22.68% | -47.76% | |||
| EBIT | 24.64% | 14.23% | |||
| EBITDA | 38.38% | 20.45% | |||
| EPS Basic | 20.00% | -25.00% | |||
| Normalized Basic EPS | 0.00% | -50.00% | |||
| EPS Diluted | 20.00% | -25.00% | |||
| Normalized Diluted EPS | 0.00% | -50.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.17% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||